Term ends Nov 26, 2033 · High confidence
20-year base term ends Nov 26, 2033
Held by BioNTech SE
Filed Oct 26, 2018 as application 16/172,063 · Granted Nov 22, 2022
Base term plus 220 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2013
2033
Clock starts
Nov 26, 2013
Nov 26, 2013
Term ends
Nov 26, 2033
Nov 26, 2033
Granted
Nov 22, 2022
Nov 22, 2022
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
220
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,155,031.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 220 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 26, 2013, when application PCT/EP2013/003559, the earliest non-provisional in its chain, was filed (this one was filed Oct 26, 2018) | Nov 26, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +220 days, USPTO patent term adjustment record | Jul 4, 2034 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,155,031) | capped to Nov 26, 2033 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 26, 2033 | High confidence |
Partial family
| Application PCT/EP2013/003559 | PCT application no patent term | no patent term |
| US 10,155,031 | In force Nov 2033 | Nov 2033 |
| US 11,504,419 | this patent Nov 2033 | Nov 2033 |
| US 12,642,844 | In force Nov 2033 | Nov 2033 |
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 1, 2018 Reel 47380, frame 821 | Sahin, Ugur | BioNTech AG; Tron-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH | Assignment of Assignor's Interest |
| Nov 1, 2018 Reel 47380, frame 846 | Paret, Claudia; Vormbrock, Kirsten; Bender, Christian; Diekmann, Jan | Tron-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH | Assignment of Assignor's Interest |
| Nov 1, 2018 Reel 47381, frame 380 | BioNTech AG | BioNTech Rna Pharmaceuticals GmbH | Assignment of Assignor's Interest |
| Nov 1, 2018 reel/frame not recorded | Sahin, Ugur | BioNTech AG | Assignment of Assignor's Interest |
| Nov 1, 2018 reel/frame not recorded | Sahin, Ugur | Tron-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH | Assignment of Assignor's Interest |
| Nov 19, 2021 Reel 58215, frame 1 | BioNTech Rna Pharmaceuticals GmbH; BioNTech SE | BioNTech SE | Merger and Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Nov 2033
Term ends Nov 26, 2033. Maintenance fees still fall due before then
Note
The 220 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,155,031.
Citations
5
later US patents cite this one
That is top 25% of utility patents granted in 2022 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.